Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Pharmacol Res. 2019 Jul 25;147:104373. doi: 10.1016/j.phrs.2019.104373

Figure 12.

Figure 12.

Structures of MNPs with wide-ranging biological targets including DNA (aaptamine), FOXO1 DNA-binding domain (tanzawaic acid D, hymenidin, cribrostatin 6 and barbamide), lipid/sterol (theonellamides A and F) and new protein target dermcidin (seriniquinone).